Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis.

Clin Mol Hepatol · 2025 · PMC11791575 · PMID 39568127

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

failed to reach statistical significanceP =0.098so close (0.05 < p ≤ 0.1)

However, the link between CRP decrease per month during follow-up and LTx-free survival closely failed to reach statistical significance in this subgroup (HR 0.881, 95% CI 0.758–1.024, P =0.098; Supplementary Table 8 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.